|
Español
English
|
Dadun >
Depósito Académico >
CIFA (Centro de Investigación en Farmacobiología Aplicada) >
Unidad de I+D de Medicamentos >
DA - CIFA - I+D de medicamentos - Artículos de revistas >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10171/18730
|
| Title: | Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships |
| Author(s) : | Mendoza, A. (Adela) Perez-Silanes, S. (Silvia) Quiliano, M. (Miguel) Pabon, A. (Adriana) Galiano, S. (S.) Gonzalez, G. (Germán) Garavito, G. (G.) Zimic, M. (Mirko) Vaisberg, A. (Abrahm) Aldana, I. (Ignacio) Monge, A. (Antonio) Deharo, E. (E.) |
| Issue Date: | 2011 |
| Publisher: | Elsevier |
| Citation: | Mendoza A, Perez-Silanes S, Quiliano M, Pabon A, Galiano S, Gonzalez G, et al. Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships. Exp Parasitol 2011 Jun;128(2):97-103. |
| Keywords: | Piperazine Pyrrolidine Antiplasmodial Plasmodium Antimalarial agents Docking studies |
| Abstract: | Piperazine and pyrrolidine derivatives were synthesized and evaluated for their capacity to inhibit the growth of Plasmodium falciparum chloroquine-resistant (FCR-3) strain in culture. The combined presence of a hydroxyl group, a propane chain and a fluor were shown to be crucial for the antiplasmodial activity. Five compounds of the aryl-alcohol series inhibited 50% of parasite growth at doses ≤ 10 µM. The most active compound 1-(4-fluoronaphthyl)-3-[4-(4-nitro-2-trifluoromethylphenyl)piperazin-1-yl]propan-1-ol was almost 20 to 40 times more active on Plasmodium falciparum (IC50: 0.5 µM) than on tumorogenic and non tumorogenic cells. Calculated physicochemical parameters showed a good potential for intestinal absorption, but due to difficulty in being solubilised prior to oral administration, it was weakly active against Plasmodium berghei infected mice (ED50: 35%). In silico molecular docking study and molecular electrostatic potential calculation revealed that this compound bound to the active site of Plasmodium plasmepsin II enzyme. |
| URI: | http://hdl.handle.net/10171/18730 |
| Publisher version (URL): | http://dx.doi.org/10.1016/j.exppara.2011.02.025 |
| Appears in Collections: | DA - Farmacia - Orgánica - Artículos de revista DA - CIFA - I+D de medicamentos - Artículos de revistas
|

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|